Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2024-08-01 | 2024-11-01 | 234280 |
| APO-AZITHROMYCIN Z | 250MG | TABLET | Resolved | 2024-09-05 | 2024-11-01 | 236867 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2019-07-03 | 2019-07-29 | 88328 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2020-01-08 | 2020-02-10 | 102531 |
| APO-BACLOFEN | 20MG | TABLET | Resolved | 2021-05-14 | 2021-08-03 | 139403 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2022-01-28 | 2022-02-11 | 153777 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2023-06-02 | 2023-08-04 | 193620 |
| APO-BACLOFEN | 20MG | TABLET | Resolved | 2023-06-29 | 2023-08-04 | 196943 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2023-07-13 | 2023-10-27 | 198470 |
| APO-BACLOFEN | 20MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210677 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2023-11-24 | 2023-12-22 | 211499 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2024-03-08 | 2024-05-24 | 221696 |
| APO-BACLOFEN | 20MG | TABLET | Resolved | 2024-03-15 | 2024-05-24 | 222455 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2024-04-12 | 2024-05-24 | 225011 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2024-07-25 | 2024-08-30 | 233703 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2017-06-28 | 2017-08-17 | 14154 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2017-10-04 | 2017-12-07 | 24328 |
| APO-BACLOFEN | 10MG | TABLET | Resolved | 2019-01-03 | 2019-02-08 | 71107 |
| APO-BACLOFEN | 20MG | TABLET | Resolved | 2018-05-22 | 2018-06-12 | 50038 |
| APO-BACLOFEN | 20MG | TABLET | Resolved | 2019-01-03 | 2019-02-08 | 71115 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |